Synjardy
Payments companies reported to CMS as associated with Synjardy. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Synjardy, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Synjardy
These are the largest totals companies reported as associated with Synjardy. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Frank Romascavage | Brodheadsville, PA | General Practice | $767.36 |
| Brian Kuronya | Bethlehem, PA | Family Medicine | $759.83 |
| Rauf Baba | Dyersburg, TN | Endocrinology, Diabetes & Metabolism | $695.97 |
| Paul Azer | Beverly Hills, CA | $674.36 | |
| Reza Nazemi | Beverly Hills, CA | Endocrinology, Diabetes & Metabolism | $673.86 |
| David Aftergood | Beverly Hills, CA | Endocrinology, Diabetes & Metabolism | $638.20 |
| Renee Chisum | San Antonio, TX | Family | $630.50 |
| Tina Copple | San Antonio, TX | Family | $627.42 |
| William Trigoso | San Antonio, TX | Endocrinology, Diabetes & Metabolism | $622.31 |
| Craig Sabre | Nazareth, PA | Neuromusculoskeletal Medicine & Omm | $617.16 |
Prescribed Synjardy?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.